Bacterial infection
Conditions
Interventions
Case series:NA
Sponsors
Department of Pharmacy, The Second Affiliated Hospital of Xi’an Jiaotong University
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1.Doctor: (1) Possess the qualifications and authority to independently prescribe antibacterial drugs; (2) During the research period, at least 100 patients who met the inclusion criteria were managed to ensure the statistical reliability of the prescription data; (3) Be proficient in using VR devices and be willing to participate. 2. Patient: (1) Adult patients aged 18 or above; (2) Receive at least one type of antibacterial drug treatment during the ICU stay; (3) The length of stay in the ICU is more than 24 hours but less than 30 days; (4) Diagnosed with infectious diseases (with clear ICD-10 codes), including but not limited to sepsis, bacterial pneumonia, urinary tract infections, etc. (5) Only patients who have undergone postoperative prophylaxis, empirical treatment, or have been confirmed to be infected with pathogenic bacteria are included. The antibacterial drug treatment is determined by the critical care physician, and there are corresponding treatment guidelines available for rationality assessment.
Exclusion criteria
Exclusion criteria: 1.Doctor: (1) Not involved in the decision-making of antibacterial drug prescriptions for ICU patients or not involved in antibacterial drug treatment; (2) Incomplete or missing records of prescriptions and decision-making for antibacterial drugs; (3) Intern doctor. 2. Patient: (1) Only using antifungal or antiviral drugs; (2) Had received antibacterial drug treatment before being admitted to the ICU; (3) The use of antibacterial drugs only for gastric motility therapy (such as erythromycin); (4) Only use non-systemic antibacterial drugs (such as topical application, nebulized inhalation, bladder irrigation, etc.); (5) Changes in the attending physician during the ICU stay; (6) Due to reasons such as transfer within 72 hours, death or consciousness disorder, the observation of the four decision-making stages cannot be completed.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comprehensive score for the rationality of antibacterial drug prescriptions; | — |
Secondary
| Measure | Time frame |
|---|---|
| The intensity of antibacterial drug use;Changes in the sensitivity of bacterial genera;The 28-day all-cause mortality rate of the patient; | — |
Countries
China
Contacts
Public ContactYan Wang
The Second Affiliated Hospital of Xi’an Jiaotong University
Outcome results
None listed